55 reports

  • GLOBAL SEXUAL DYSFUNCTION DRUGS MARKET SEGMENTATION BY THERAPY 2016
  • SEXUAL DYSFUNCTION DRUGS MARKET IN AMERICAS 2016-2021 ($ MILLIONS)

About Sexual Dysfunction Drugs Sexual dysfunctions include sexual disorders of men and women that can interfere with their sexual performance, leading to unsatisfied sexual intercourse. The major drugs used in this market are PDE5 inhibitors, whereas other drugs such as hormone-related and transurethral also have a presence in...

  • Dysfunction Drug
  • World
  • AbbVie Inc.
  • Eli Lilly & Co.
  • Pfizer Inc.
  • ERECTILE DYSFUNCTION MARKET
  • 21 LATIN AMERICA: ERECTILE DYSFUNCTION MARKET

This market research report on the erectile dysfunction market offers analysis on market size and forecast, market share, industry trends, growth drivers, and vendor analysis. The study also includes insights on segmentation by therapy type (drug therapies and device therapies) and geography (APAC, Europe, Latin America, MEA, and North America). Erectile...

  • Dysfunction Drug
  • World
  • Forecast
  • Market Size
  • Pfizer Inc.
  • Global erectile dysfunction treatment market by product
  • Global ED treatment market by product 2015 and 2020

About Erectile Dysfunction The loss of erection can be attributed to various factors such as high blood pressure, aging, diabetes mellitus, smoking, alcoholism, depression, nerve or spinal cord damage, and low testosterone levels. The condition can be treated with a broad range of drugs and implants available in the market. Technavio’s...

  • Dysfunction Drug
  • Boston Scientific Corporation
  • Coloplast Group
  • Eli Lilly & Co.
  • Pfizer Inc.

Erectile Dysfunction Drugs Market - Global Industry Analysis, Pipeline Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026 ##.

  • Dysfunction Drug
  • Therapy
  • World
  • Company Financials
  • Market Size

The 2019-2024 World Outlook for Erectile Dysfunction Drugs ## INTRODUCTION ##. ## OVERVIEW ##. ## WHAT IS LATENT DEMAND AND THE P. I. E.?

  • Dysfunction Drug
  • Therapy
  • World
  • Demand

Global Erectile Dysfunction Epidemiology and Patient Flow Analysis - 2017 ##.

  • Dysfunction Drug
  • Therapy
  • United States
  • World
  • Forecast

Erectile Dysfunction - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018 ##.

  • Dysfunction Drug
  • United States
  • World
  • Demand
  • Product Initiative

Erectile Dysfunction Phase ## Clinical Trials, 2016 ##.

  • Dysfunction Drug
  • Therapy
  • France
  • United States
  • Market Shares

Erectile Dysfunction - Epidemiology Forecast to 2027 ##.

  • Dysfunction Drug
  • France
  • Germany
  • Italy
  • Spain

Europe Erectile Dysfunction Epidemiology and Patient Flow Analysis - 2017 ##.

  • Dysfunction Drug
  • Europe
  • France
  • Germany
  • Forecast
  • FEATURES OF ERECTILE DYSFUNCTION PATIENTS
  • Prevalence of Erectile Dysfunction, males (000s)

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Erectile Dysfunction in 29 Major Markets Erectile dysfunction, also known as ED and impotence, is defined as the frequent inability to achieve or maintain an erection sufficient for sexual activity to take place. This report provides the current prevalent population...

  • Dysfunction Drug
  • Pharmaceutical
  • Therapy

Drug A: Company ## ##. ##. ##.

  • Dysfunction Drug
  • Therapy
  • United States
  • Market Shares
  • Increasing Demand For Low-Cost Erectile Dysfunction Drugs
  • Demand For Combination Products

The genitourinary drugs market covers drugs that are used in the treatment of diseases such as urinary tract infections, male reproductive diseases, voiding diseases, female reproductive diseases, glomerular disorders, urinary calculi, cystic kidney disease, Reno vascular diseases, benign prostate diseases, and other related diseases. North...

  • Dysfunction Drug
  • World
  • Bayer AG
  • Daiichi Sankyo Company
  • Pfizer Inc.

US Market Report for Erectile Dysfunction Devices 2016 - MedCore TABLE OF CONTENTS I LIST OF FIGURES III LIST OF CHARTS IV EXECUTIVE SUMMARY ## ##. ## U. S.

  • Dysfunction Drug
  • Therapy
  • United States
  • Increasing Demand For Low-Cost Erectile Dysfunction Drugs
  • Demand For Combination Products

The genitourinary drugs market covers drugs that are used in the treatment of diseases such as urinary tract infections, male reproductive diseases, voiding diseases, female reproductive diseases, glomerular disorders, urinary calculi, cystic kidney disease, Reno vascular diseases, benign prostate diseases, and other related diseases. The...

  • Dysfunction Drug
  • World
  • Bayer AG
  • Daiichi Sankyo Company
  • Pfizer Inc.

Erectile Dysfunction Phase ## Clinical Trials, 2016 ##.

  • Dysfunction Drug
  • France
  • Germany
  • Italy
  • Market Shares
  • ERECTILE DYSFUNCTION DEVICES
  • ERECTILE DYSFUNCTION DEVICES GLOBAL MARKET REVENUE, BY PRODUCTS (2015-2023) ($MN)

Urology devices are medical devices used for diagnosis and treatment of kidney and urology diseases. The emerging trend in urological surgical procedures is the preference for use of minimally invasive devices due to advantages such as fewer incisions, faster recovery rate and less hospital stays compared to open surgical intervention....

  • Dysfunction Drug
  • World
  • Market Size
  • Baxter International Inc.
  • Boston Scientific Corporation

Erectile Dysfunction Phase ## Clinical Trials, 2016 ##.

  • Dysfunction Drug
  • Therapy
  • United States
  • Forecast
  • Market Shares

Erectile Dysfunction Phase ## Clinical Trials, 2016 ##.

  • Dysfunction Drug
  • Therapy
  • Japan
  • Forecast
  • Market Shares

Erectile Dysfunction Phase ## Clinical Trials, 2016 ##.

  • Dysfunction Drug
  • Therapy
  • United Kingdom
  • Forecast
  • Market Shares

Erectile Dysfunction Phase ## Clinical Trials, 2016 ##.

  • Dysfunction Drug
  • Therapy
  • Italy
  • Forecast
  • Market Shares

Erectile Dysfunction Phase ## Clinical Trials, 2016 ##.

  • Dysfunction Drug
  • Therapy
  • Germany
  • Forecast
  • Market Shares

Erectile Dysfunction Phase ## Clinical Trials, 2016 ##.

  • Dysfunction Drug
  • Therapy
  • France
  • Forecast
  • Market Shares

Male and Female Sexual Dysfunctions: Drug Market Report and Forecasts 2016-2026 ##.

  • Dysfunction Drug
  • Pharmaceutical
  • Therapy
  • World
  • Market Size

Erectile Dysfunction Phase ## Clinical Trials, 2016 ##.

  • Dysfunction Drug
  • Therapy
  • Spain
  • Forecast
  • Market Shares

The total market for erectile dysfunction treatment devices includes inflatable erectile dysfunction devices and malleable erectile dysfunction devices.

  • Dysfunction Drug
  • Therapy
  • Europe
  • Erectile Dysfunction - Therapeutics Development
  • Erectile Dysfunction - Drug Profiles

Erectile Dysfunction - Pipeline Review, H2 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Erectile Dysfunction - Pipeline Review, H2 2018, provides an overview of the Erectile Dysfunction (Male Health) pipeline landscape. Erectile dysfunction,...

  • Dysfunction Drug
  • United States
  • World
  • Product Initiative
  • Apricus Biosciences, Inc.
  • Erectile Dysfunction - Overview
  • Erectile Dysfunction - Therapeutics Development

Erectile Dysfunction - Pipeline Review, H1 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Erectile Dysfunction - Pipeline Review, H1 2018, provides an overview of the Erectile Dysfunction (Male Health) pipeline landscape. Erectile dysfunction,...

  • Dysfunction Drug
  • Pharmaceutical
  • United States
  • Product Initiative
  • Apricus Biosciences, Inc.
  • LATEST CLINICAL TRIALS NEWS ON ERECTILE DYSFUNCTION
  • ERECTILE DYSFUNCTION THERAPEUTICS, GLOBAL, CLINICAL TRIALS BY REGION (%), 2018*

Erectile Dysfunction Global Clinical Trials Review, H1, 2018 Summary GlobalData’s clinical trial report, “Erectile Dysfunction Global Clinical Trials Review, H1, 2018" provides an overview of Erectile Dysfunction clinical trials scenario.This report provides top line data relating to the clinical...

  • Clinical Trial
  • Dysfunction Drug
  • Pharmaceutical
  • Therapy
  • World
  • List of abbreviations
  • Highlights

About the Penile Implants Market ED is typically caused by various conditions including congenital anomalies, iatrogenesis, vascular conditions (including cardiovascular disease, diabetes, and high blood pressure), Peyronie's disease, penile or pelvic trauma, and complications in treating prostate cancer. Penile implants, or penile...

  • Dysfunction Drug
  • Medical Device
  • Prosthesis
  • World
  • Market Size